Latest Anticonvulsants Stories
As Businessweek reported on October 30, a Philadelphia jury said that J&J's Janssen must pay $4 million in a lawsuit claiming that Topamax caused birth defects.
New Northwestern Medicine® research offers one of the first in-depth studies of how physiological changes during pregnancy reduce the effects of a commonly used drug to treat bipolar disorder, making women more vulnerable to recurring episodes.
50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression.
On August 17, Bloomberg published that a federal court complaint was filed accusing Abbott Labs of racketeering in an effort to promote Depakote for unapproved uses.
A medication currently approved by the US Food and Drug Administration to treat epilepsy and migraines could also be the first drug capable of effectively treating cocaine addiction, according to new research published in the journal JAMA Psychiatry.
Throughout June and August 2013, investors and health plans are going after Depakote manufacturer Abbott Laboratories with a lawsuit regarding its marketing practices.
As Businessweek published on October 15, a new trial started alleging that the plaintiff's son was born with birth defects resulting from her use of Topamax.
- An aromatic woolly plant (Origanum dictamnus) native to Crete, formerly believed to have magical powers.